Together, these results demonstrate that oAd/shErbB3 exerted potent antitumor efficacy via robust inhibition of ErbB3 expression and inhibition of tumor cell proliferation, and enhanced induction of apoptosis in the tumor tissues. The gene discussed is ERBB3; the disease is neoplasm.